Pulmonx (Lung) 2025 Earnings Outlook for Investors
Pulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...
Fundamental analysis is key to maximizing stock returns. By evaluating financial health, you can make informed investment choices that lead to higher profits.
22,179 articlesPulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...
Carnival reports a sharp rise in adjusted earnings for 2025 and improves leverage metrics, even as fuel costs and sec...
Block, Palantir, Atlassian, and Salesforce are in the spotlight as layoffs and hiring pauses test how cost cuts affec...
When insiders sell, investors watch closely. This article unpacks a recent move at Laureate Education and translates ...
Bakkt faces a pivotal year as crypto markets evolve and cash flow models mature. This guide explains what bakkt (bkkt...
Many investors chase flashy AI startups, but the real potential may lie in Amazon's infrastructure. AWS powers the AI...
LadderUp Housing secures a multi-year investment from the Richard King Mellon Foundation to broaden its rent-to-homeo...
As SPIR prepares for 2025, investors want clarity on revenue mix, profitability, and cash flow. This guide breaks dow...
Anthropic filed confidentially for an IPO on June 1, 2026, signaling a landmark tech debut. For individual investors,...
Investors are weighing a mid-year drop in Booking Holdings against solid fundamentals. This guide explains how to ass...
Oil climbs and stock futures rise as renewed U.S.-Iran clashes raise supply disruption fears in the Persian Gulf.
Palantir rallies on stronger AI demand and improving margins, positioning it as a core pick in this best stocks 2026 ...